Have a personal or library account? Click to login
Evaluation of routine laboratory markers as short-term outcome indicators in patients with acute ischemic stroke Cover

Evaluation of routine laboratory markers as short-term outcome indicators in patients with acute ischemic stroke

Open Access
|May 2024

References

  1. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003 Oct;362(9391):1211-24. DOI: 10.1016/S0140-6736(03)14544-8
  2. National Statistical Institute of Republic Bulgaria. https://www.nsi.bg/en/content/3357/mortality-causes-sex-statistical-regions-and-districts
  3. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020 Oct 15;21(20):7609. DOI: 10.3390/ijms21207609
  4. Melake MS, El-Kabanya RA, Al-Emama AI, El-Shereefa AM, Okdaa M. The Role of D-Dimer, Fibrinogen and C-Reactive Protein as Plasma Biomarkers in Acute Ischemic Stroke. J Neurol Res. 2016 Jan; 5(6):277-82. DOI: 10.14740/jnr362w
  5. Liu LB, Li M, Zhuo WY, Zhang YS, Xu AD. The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke. PLoS One. 2015 Feb;10(2):e0118301. DOI: 10.1371/journal.pone.0118301
  6. Tirandi A, Sgura C, Carbone F, Montecucco F, Liberale L. Inflammatory biomarkers of ischemic stroke. Intern Emerg Med. 2023 Apr;18(3):723-32. DOI: 10.1007/s11739-023-03201-2
  7. Yu B, Yang P, Xu X, Shao L. C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Biosci Rep. 2019 Feb;39(2):BSR20181135. DOI: 10.1042/BSR20181135
  8. Chen L, Wang M, Yang C, Wang Y, Hou B. The role of high-sensitivity C-reactive protein serum levels in the prognosis for patients with stroke: a meta-analysis. Front Neurol. 2023 Jun;14:1199814. DOI: 10.3389/fneur.2023.1199814
  9. Cai Z, He W, Zhuang FJ, Chen Y. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke. Int J Neurosci. 2019 May;129(5):423-9. DOI: 10.1080/00207454.2018.1538139
  10. Shoaeb MA, Shehata MA, Taema KM, Hammouda MA. CRP in cerebrovascular stroke: Prognostic implications. Egypt. J. Crit. Care Med. 2014 Apr;2(1):43-52. DOI: 10.1016/j.ejccm.2014.03.001
  11. Herrero-Fernandez B, Gomez-Bris R, Somovilla-Crespo B, Gonzalez-Granado JM. Immunobiology of Atherosclerosis: A Complex Net of Interactions. Int J Mol Sci. 2019 Oct;20(21):5293. DOI: 10.3390/ijms20215293
  12. Haapaniemi E, Tatlisumak T. Is D-dimer helpful in evaluating stroke patients? A systematic review. Acta Neurol Scand. 2009 Mar;119(3):141-50. DOI: 10.1111/j.1600-0404.2008.01081.x
  13. Park YW, Koh EJ, Choi HY. Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke. J Korean Neurosurg Soc. 2011 Aug;50(2):89-94. DOI: 10.3340/jkns.2011.50.2.89
  14. Nam KW, Kwon HM, Lee YS. Clinical significance of D-dimer levels during acute period in ischemic stroke. Thromb J. 2023 May;21(1):55. DOI: 10.1186/s12959-023-00496-1
  15. Yao T, Tian BL, Li G, Cui Q, Wang CF, Zhang Q, et al. Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study. BMC Neurol. 2019 Jul;19(1):175. DOI: 10.1186/s12883-019-1386-3
  16. Bao Q, Zhang J, Wu X, Zhao K, Guo Y, Yang M, Du X. Clinical Significance of Plasma D-Dimer and Fibrinogen in Outcomes after Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2023 Oct;52(3):318-43. DOI: 10.1159/000526476
  17. Di Napoli M, Singh P. Is plasma fibrinogen useful in evaluating ischemic stroke patients? why, how, and when. Stroke. 2009 May;40(5):1549-52. DOI: 10.1161/STROKEAHA.108.537084
  18. Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium in Stroke. Circ Res. 2016 Jun;119(1):142-58. DOI: 10.1161/CIRCRESAHA.116.308022
  19. Wolf MP, Hunziker P. Atherosclerosis: Insights into Vascular Pathobiology and Outlook to Novel Treatments. J Cardiovasc Trans Res. 2020 Oct;13(5):744-57. DOI: 10.1007/s12265-020-09961-y
  20. Lyden PD. Thrombolytic Therapy for Acute Ischemic Stroke. Stroke. 2019 Sep;50(9):2597-603. DOI: 10.1161/STROKEAHA.119.025699
  21. Sughrue T, Swiernik MA, Huang Y, Brody JP. Laboratory tests as short-term correlates of stroke. BMC Neurol. 2016 Jul;16:112. DOI: 10.1186/s12883-016-0619-y
  22. Esmaeilzadeh A, Zarerafie M, Mohammadzadeh A. Cross-Talk of Atherosclerosis and Ischemic Stroke: Dramatic Role of Neutrophils. Arch Neurosci. 2021;8(2):e104433. DOI: 10.5812/ans.104433
  23. Ohara T, Farhoudi M, Bang OY, Koga M, Demchuk AM. The emerging value of serum D-dimer measurement in the work-up and management of ischemic stroke. Int J Stroke. 2020 Feb;15(2):122-31. DOI: 10.1177/1747493019876538
  24. Lu T, Xian W, Liang J, Yang H, Weng B. Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis. Medicine (Baltimore). 2018 Mar;97(13):e0241. DOI: 10.1097/MD.0000000000010241
  25. Vandelli L, Marietta M, Gambini M, Cavazzuti M, Trenti T, Cenci MA, et al. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2015 Feb;24(2):394-400. DOI: 10.1016/j.jstrokecerebrovasdis.2014.09.005
  26. Yan S, Zhang X, Zhang R, Xu J, Lou M. Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage After Reperfusion Therapy. Stroke. 2019 Oct;50(10):2716-21. DOI: 10.1161/STROKEAHA.119.025711
  27. You CJ, Liu D, Liu LL, Liu QQ, Li GZ. Correlation between Fibrinogen and White Matter Hyperintensities among Nondiabetic Individuals with Noncardiogenic Ischemic Stroke. J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2360-6. DOI: 10.1016/j. jstrokecerebrovasdis.2018.04.025
  28. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004 Oct;35(10):2300-5. DOI: 10.1161/01.STR.0000141701.36371.d1
  29. Mehta V, Sharma A, Jyoti D, Prabhakar R, Kumar R, Guria RT et al. Fibrinogen as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke - Evidence from the Indian Population. J Cent Nerv Syst Dis. 2023 Feb;15:11795735231156349. DOI: 10.1177/11795735231156349
  30. Hou HQ, Xiang XL, Pan YS, Zhang QH, Li H, Meng X, et al. Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry III. Atherosclerosis. 2021 Oct 18;337:35-41. DOI: 10.1016/j.atherosclerosis.2021.10.002
  31. Peycheva M, Deneva T, Zahariev Z. The role of fibrinogen in acute ischaemic stroke. Neurol Neurochir Pol. 2021 Jan;55(1):74-80 DOI: 10.5603/PJNNS.a2020.0094
  32. Bhaskar P, Rao B, Rajender. A study of high sensitivity C-reactive protein (hs-CRP) levels in cerebrovascular accident (stroke). J. Evolution Med. Dent. Sci. 2016 Aug;5(65):4655-60. DOI: 10.14260/jemds/2016/1061
  33. Rocco A, Ringleb PA, Grittner U, Nolte CH, Schneider A, Nagel S. Follow-up C-reactive protein level is more strongly associated with outcome in stroke patients than admission levels. Neurol Sci. 2015 Dec;36(12):2235-41. DOI: 10.1007/s10072-015-2342-7
  34. Chaudhuri JR, Mridula KR, Umamahesh M, Swathi A, Balaraju B, Bandaru VC. High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center. Iran J Neurol. 2013;12(3):92-7.
  35. Vikasdeep B, Komal A. Reliability of C-reactive protein as a predictor of early neurological deficit in acute ischemic stroke-is it only to be blamed? a retrospective observational study. Int J Res Med Sci. 2020 Apr;8(4):1208-12. DOI: 10.18203/2320-6012. ijrms20201009
  36. AlTaweel YAAH, Nageeb RS, Metwally PM, Badawy AE. Role of some inflammatory biomarkers in prediction of short-term outcome in acute ischemic stroke. Egypt J Neurol Psychiatry Neurosurg. 2021 Mar;57(41):2021. DOI: 10.1186/s41983-021-00294-4
DOI: https://doi.org/10.2478/rrlm-2024-0011 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 155 - 162
Submitted on: Feb 5, 2024
Accepted on: Mar 6, 2024
Published on: May 2, 2024
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Tatyana Popovska, Rosen Kalpachki, Dobrin Svinarov, Milena Velizarova, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.